We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
SELLAS Life Sciences Group Inc | NASDAQ:SLS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.03 | -2.22% | 1.32 | 0.80 | 1.33 | 1.37 | 1.29 | 1.36 | 786,873 | 05:00:11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
001-33958
|
|
20-8099512
|
(State or other jurisdiction of incorporation or organization)
|
|
(Commission
File Number) |
|
(I.R.S. Employer
Identification No.) |
|
|
|
|
|
|
|
2000 Crow Canyon Place, Suite 380, San Ramon, CA 94583
|
|
|
|
|
(Address of Principal Executive Offices) (Zip Code)
|
|
|
|
|
|
|
|
Registrant’s telephone number, including area code: (855) 855-4253
|
||||
|
|
|
|
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 3.01
|
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GALENA BIOPHARMA, INC.
|
||||
|
|
|
|
|
||||
Date:
|
|
August 16, 2016
|
|
|
|
By:
|
|
/s/ Mark W. Schwartz
|
|
|
|
|
|
|
|
|
Mark W. Schwartz Ph.D.
President and Chief Executive Officer
|
1 Year SELLAS Life Sciences Chart |
1 Month SELLAS Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions